An assessment of the interindividual variability of internal dosimetry during multi-route exposure to drinking water contaminants

International Journal of Environmental Research and Public Health

Volumn 7, Issue 11, 2010, Pages 4002-4022

  Valcke, Mathieu ^a   Krishnan, Kannan ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Drinking water contaminants; Inter individual variability; Liter equivalents; Multi route exposure; Physiologically based pharmacokinetic modeling

Indexed keywords

CHLOROFORM; DRINKING WATER; TETRACHLOROETHYLENE; TRICHLOROETHYLENE;

ABSORPTION; AGE; ARTICLE; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; FLUID INTAKE; MONTE CARLO METHOD; SIMULATION; WATER CONTAMINATION;

TETRA;

EID: 78649708158     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph7114002     Document Type: Article

References (56)

1. Sidhu, K.S. Standard setting processes and regulations for environmental contaminants in drinking water: state versus federal needs and viewpoints. Regul. Toxicol. Pharmacol. 1991, 13, 293-308.
2. Jo, W.K.; Weisel, C.P.; Lioy, P.J. Chloroform exposure and the health risk associated with multiple uses of chlorinated tap water. Risk Anal. 1990, 10, 581-585.
3. Jo, W.K.; Weisel, C.P.; Lioy, P.J. Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal. 1990, 10, 575-580.
4. Weisel, C.P.; Jo, W.K. Ingestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water. Environ. Health Perspect. 1996, 104, 48-51.
5. Xu, X.; Weisel, C.P. Dermal uptake of chloroform and haloketones during bathing. J. Expo. Anal. Environ. Epidemiol. 2005, 15, 289-296.
6. Xu, X.; Weisel, C.P. Human respiratory uptake of chloroform and haloketones during showering. J. Expo. Anal. Environ. Epidemiol. 2005, 15, 6-16.
7. Backer, L.C.; Ashley, D.L.; Bonin, M.A.; Cardinali, F.L.; Kieszak, S.M.; Wooten, J.V. Household exposures to drinking water disinfection by-products: Whole blood trihalomethane levels. J. Expo. Anal. Environ. Epidemiol. 2000, 10, 321-326.
8. Buteau, S.; Valcke, M. Probabilistic human health risk assessment for quarterly exposure to high chloroform concentrations in drinking water distribution network of the province of Quebec, Canada. J. Toxicol. Environ. Health A 2010, 73, 1626-1644.
9. Haddad, S.; Tardif, G.C.; Tardif, R. Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: trichloroethylene and trihalomethanes. J. Toxicol. Environ. Health A 2006, 69, 2095-2136.
10. Levesque, B.; Ayotte, P.; Tardif, R; Ferron, L.; Gingras, S.; Schlouch, E.; Gingras, G.; Levallois, P.; Dewailly, E. Cancer risk associated with household exposure to chloroform. J. Toxicol. Environ. Health A 2002, 65, 489-502.
11. Rao, H.V.; Brown, D.R. A physiologically based pharmacokinetic assessment of tetrachloroethylene in groundwater for a bathing and showering determination. Risk Anal. 1993, 13, 37-49.
12. Rao, H.V.; Ginsberg, G.L. A physiologically-based pharmacokinetic model assessment of methyl t-butyl ether in groundwater for a bathing and showering determination. Risk Anal. 1997, 17, 583-598.
13. Public Health Goal for Trichloroethylene in Drinking Water; Pesticide and Environmental Toxicology Branch OoEHRAH 2009; California Environmental Protection Agency: Sacramento, CA, USA, 2009.
14. Health Canada. Guidelines for Canadian Drinking Water Quality: Supporting Documentation- Trichloroethylene; Water Quality and Health Bureau: Ottawa, Canada, 2005.
15. Health Canada. Guidelines for Canadian Drinking Water Quality: Supporting Documentation- Trihalomethanes; Water Quality and Health Bureau: Ottawa, Canada, 2006.
16. Health Canada. Guidelines for Canadian Drinking Water Quality: Supporting Documentation- Tetrachloroethylene; Water Quality and Health Bureau: Ottawa, Canada, 1995.
17. Chemical-Specific Adjustment Factors (CSAFs) for Interspecies Differences and Human Variability: Guidance Document for the Use of Data in Dose/Concentration-Response Assessment; Report No.: WHO/IPCS/01.4; World Health Organisation (WHO): Geneva, Switzerland, 2005.
18. Krishnan, K.; Carrier, R. Approaches for evaluating the relevance of multiroute exposures in establishing guideline values for drinking water contaminants. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 2008, 26, 300-316.
19. Brochu, P.; Ducré-Robitaille, J.F.; Brodeur, J. Physiological daily inhalation rates for free-living pregnant and lactating adolescents and women aged 11 to 55 years, using data from doubly labelled water measurements for use in health risk assessment. Human Ecol. Risk. Assess. 2006, 12, 702-735.
20. Faustman, E.M.; Ribeiro, P. Pharmacokinetic consideration in developmental toxicity. In Developmental Toxicology: Risk Assessment and the Future; Hood, R.D., Ed.; Van Nostrand Reinhold: New York, NY, USA, 1990; pp. 109-136.
21. Valcke, M.; Krishnan, K. Evaluation of the impact of the exposure route on the human kinetic adjustment factor. Regul. Toxicol. Pharmacol. 2010, doi:10.1016/j.yrtph.2010.10.008.
22. Haddad, S.; Pelekis, M.; Krishnan, K. A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares. Toxicol. Lett. 1996, 85, 113-126.
23. Thomas, R.S.; Bigelow, P.L.; Keefe, T.J.; Yang, R.S. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. Am. Ind. Hyg. Assoc. J. 1996, 57, 23-32.
24. Tan, Y.M.; Liao, K.H.; Clewell, H.J., III. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling. J. Expo. Sci. Environ. Epidemiol. 2007, 17, 591-603.
25. Taniguchi, H.; Oguro, A.; Koyama, H.; Masuyama, M.; Takahashi, T. Analysis of models for quantification of arterial and portal blood flow in the human liver using PET. J. Comput. Assist. Tomogr. 1996, 20, 135-144.
26. Sarangapani, R.; Gentry, P.R.; Covington, T.R.; Teeguarden, J.G.; Clewell, H.J., III. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol. 2003, 15, 987-1016.
27. Johnsrud, E.K.; Koukouritaki, S.B.; Divakaran, K.; Brunengraber, L.L.; Hines R.N.; McCarver, D.G. Human hepatic CYP2E1 expression during development. J. Pharmacol. Exp. Ther. 2003, 307, 402-407.
28. Lipscomb, J.C; Teuschler, L.K; Swartout, J; Swan, G.E; Snawder, J.E Variance of microsomal protein and cytochrome P450 2E1 and 3A forms in adult human liver. Toxicol. Mech. Meth. 2003, 13, 45-51.
29. Price, P.S.; Conolly, R.B.; Chaisson, C.F.; Gross, E.A.; Young, J.S.; Mathis, E.T.; Tedder, D.R. Modeling interindividual variation in physiological factors used in PBPK models of humans. Crit. Rev. Toxicol. 2003, 33, 469-503.
30. DeWoskin, R.S.; Thompson, C.M. Renal clearance parameters for PBPK model analysis of early lifestage differences in the disposition of environmental toxicants. Regul Toxicol Pharmacol 2008, 51, 66-86.
31. ICRP. Annals of the ICRP. ICRP Publication 89. Ann. ICRP 2002, 32, 5-265.
32. Nelson, W.E. Textbook of Pediatrics, 15th ed.; W.B. Sauders Company: New York, NY, USA, 1991.
33. Exposure Factor Handbook; US Environmental Protection Agency: Washington, DC, USA, 1997.
34. Estimated Per Capita Water Ingestion and Body Weight in the United States-An Update; Report No.: EPA-822-R-00-001; US Environmental Protection Agency: Washington, DC, USA, 2004.
35. Corley, R.A.; Mendrala, A.L.; Smith, F.A.; Staats, D.A.; Gargas, M.L.; Conolly, R.B.; Andersen, M.E.; Reitz, R.H. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 1990, 103, 512-527.
36. Poulin, P.; Krishnan, K. A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicals. Hum. Exp. Toxicol. 1995, 14, 273-280.
37. Klingler, M.; Demmelmair, H.; Larque, E.; Koletzko, B. Analysis of FA contents in individual lipid fractions from human placental tissue. Lipids 2003, 38, 561-566.
38. Toxicological Profile for Chloroform; Agency for Toxic Substances and Disease Registry: Atlanta, GA, USA, 1997.
39. Clewell, H.J.; Gentry, P.R.; Kester, J.E.; Andersen, M.E. Evaluation of physiologically based pharmacokinetic models in risk assessment: An example with perchloroethylene. Crit. Rev. Toxicol. 2005, 35, 413-433.
40. Gearhart, J.M.; Mahle, D.A.; Greene, R.J.; Seckel, C.S.; Flemming, C.D.; Fisher, J.W.; Clewell, H.J., III. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol. Lett. 1993, 68, 131-144.
41. Clewell, H.J.; III; Gentry, P.R.; Covington, T.R.; Gearhart, J.M. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 2000, 108, 283-305.
42. Soucek, B.; Vlachova, D. Excretion of trichloroethylene metabolites in human urine. Br. J. Ind. Med. 1960, 17, 60-64.
43. Toxicological Profile for Trichloroethylene; Agency for Toxic Substances and Disease Registry: Atlanta, GA, USA, 1997.
44. McKone, T.E. Human exposure to volatile organic compounds in household tapwater: the indoor inhalation pathway. Environ. Sci. Technol. 1987, 21, 1194-1201.
45. Gargas, M.L.; Burgess, R.J.; Voisard, D.E.; Cason, G.H.; Andersen, M.E. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 1989, 98, 87-99.
46. Toxicological Profile for Tetrachloroethylene; Agency for Toxic Substances and Disease Registry: Atlanta, GA, USA, 1997.
47. McKone, T.E.; Knevzovitch, J.P. The transfer of trichloroethylene (TCE) from shower to indoor air: experimental measurements and their implications. J. Air Waster Manage. Assoc. 1991, 40, 282-286.
48. Lindstrom, A.B.; Highsmith, V.R.; Buckley, T.J.; Pate, W.J.; Michael L.C. Gasoline-contaminated ground water as a source of residential benzene exposure: a case study. J. Expo. Anal. Environ. Epidemiol. 1994, 4, 183-195.
49. Statistics Canada. Canadian community health survey, cycle 2.1. Statistics Canada, 2003. Available online: http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl?Function=getSurvey&SurvId=3226&SurvVer=0&SDDS=3226&InstaId=15282&InstaVer=2&lang=en&db=imdb&adm=8&dis=2 (accessed on 2 February 2010).
50. Meek, M.E.; Renwick, A.; Ohanian, E.; Dourson, M.; Lake, B.; Naumann, B.D.; Vu, V. Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment. Toxicology 2002, 181-182, 115-120.
51. Dorne, J.L.; Renwick, A.G. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol. Sci. 2005, 86, 20-26.
52. Clewell, H.J.; Teeguarden, J.; McDonald, T.; Sarangapani, R.; Lawrence, G.; Covington, T.; Gentry, R.; Shipp, A. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Crit. Rev. Toxicol. 2002, 32, 329-389.
53. Valcke, M.; Krishnan, K. Physiologically based pharmacokinetic modeling in the risk assessment of developmental toxicants. In Developmental Toxicology; Hansen, D.K., Abbott B.D., Eds.; Informa Healthcare: New York, NY, USA, 2009; pp. 243-274.
54. Integrated Risk Information System. US Environmental Protection Agency, 2010. Available online: http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList&list_type=alpha&view=C (accessed on 15 November 2010).
55. 2009 Edition of the Drinking Water Standards and Health Advisories; EPA/822/R/09/011; Office of Water, US Environmental Protection Agency: Washington, DC, USA, 2009. Available online: http://water.epa.gov/action/advisories/drinking/upload/dwstandards2009.pdf (accessed on 15 November 2010).
56. Mahle, D.A.; Gearhart, J.M.; Grigsby, C.C.; Mattie, D.R.; Barton, H.A.; Lipscomb, J.C.; Cook, R.S. Age-dependent partition coefficients for a mixture of volatile organic solvents in Sprague-Dawley rats and humans. J. Toxicol. Environ. Health A 2007, 70, 1745-1751.